Scarless Wound Healing Mechanisms in Fetal Systems

In fetal mammals, wounds heal rapidly and without scar formation owing to a finely tuned interplay among cellular, molecular and extracellular components. Unlike adults, fetal skin exhibits a predominance of hyaluronan-rich matrices, reduced inflammatory cell infiltration and a balanced ratio of collagen III to collagen I, which collectively support regenerative closure rather than fibrotic repair. Fetal fibroblasts display a unique phenotype characterised by enhanced migratory and proliferative capacity, lower apoptosis rates and a propensity to differentiate into cells that deposit organised extracellular matrix. Key signalling pathways, notably those mediated by transforming growth factor-β isoforms, interleukin-10 and specialised microRNAs, are differentially regulated to favour a pro-regenerative environment. Moreover, the fetal immune response is skewed towards anti-inflammatory profiles, limiting pro-fibrotic cytokine release. Understanding these mechanisms has opened avenues for biomaterial design, cell-based therapies and molecular interventions aimed at recapitulating scarless healing in adult tissues, with implications for chronic wound management and tissue engineering.

Research from Nature Portfolio

Recent studies have employed single-cell transcriptomics to delineate fibroblast subpopulations in mid-gestation skin wounds, revealing a subset that expresses elevated anti-fibrotic markers and extracellular matrix remodelling genes. These cells contribute to rapid matrix deposition without scar formation. Parallel immunological profiling has identified a pro-regenerative macrophage phenotype in the fetal wound bed that secretes interleukin-10 and limits neutrophil recruitment, thus suppressing chronic inflammation. Advanced biomaterial investigations have further compared the viscoelastic properties of fetal versus adult matrices, demonstrating that fetal analogues enriched in glycosaminoglycans and elastin support stem cell engraftment and vascular integration in engineered grafts, paving the way for translational applications in regenerative medicine.

Scarless Wound Healing Mechanisms in Fetal Systems publication trend

The graph below shows the total number of articles in scarless wound healing mechanisms in fetal systems across all publications each year (not limited to Nature Index journals).

Technical terms

Extracellular matrix (ECM): The complex network of collagen, proteoglycans and glycoproteins that provides structural and biochemical support to cells.

Fibroblast heterogeneity: The existence of distinct fibroblast subtypes with specialised functions influencing wound repair outcomes.

Transforming growth factor-β (TGF-β): A family of cytokines that regulate cell proliferation, differentiation and extracellular matrix deposition, with isoform-specific roles in scarring versus regeneration.

Hyaluronan: A glycosaminoglycan abundant in fetal wounds that promotes cell migration, modulates inflammation and maintains tissue hydration.

Myofibroblast: A specialised cell derived from fibroblasts that contracts wound edges but can also contribute to scar tissue formation if dysregulated.

References

1. Comprehensive Characterization of Tissues Derived from Animals at Different Regenerative Stages: A Comparative Analysis between Fetal and Adult Mouse Skin. Cells (2023).
2. Potential Role of AGR2 for Mammalian Skin Wound Healing. International Journal of Molecular Sciences (2023).
3. The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation. Journal of Biological Chemistry (2021).
4. The Role of Interleukin-10 and Hyaluronan in Murine Fetal Fibroblast Function In Vitro: Implications for Recapitulating Fetal Regenerative Wound Healing. PLOS ONE (2015).
5. Dynamic Expression of Novel MiRNA Candidates and MiRNA-34 Family Members in Early- to Mid-Gestational Fetal Keratinocytes Contributes to Scarless Wound Healing by Targeting the TGF-β Pathway. PLOS ONE (2015).